1. Home
  2. BRBS vs MYGN Comparison

BRBS vs MYGN Comparison

Compare BRBS & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Ridge Bankshares Inc.

BRBS

Blue Ridge Bankshares Inc.

HOLD

Current Price

$4.01

Market Cap

355.2M

Sector

Finance

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$3.88

Market Cap

327.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRBS
MYGN
Founded
1893
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.2M
327.1M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
BRBS
MYGN
Price
$4.01
$3.88
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$7.64
AVG Volume (30 Days)
1.7M
1.6M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
24.78%
N/A
EPS Growth
135.48
N/A
EPS
N/A
N/A
Revenue
$111,284,000.00
$771,400,000.00
Revenue This Year
N/A
$6.86
Revenue Next Year
N/A
$5.45
P/E Ratio
N/A
N/A
Revenue Growth
123.99
2.33
52 Week Low
$3.23
$2.74
52 Week High
$4.79
$8.59

Technical Indicators

Market Signals
Indicator
BRBS
MYGN
Relative Strength Index (RSI) 70.14 59.37
Support Level $3.88 $3.53
Resistance Level $4.08 $5.42
Average True Range (ATR) 0.07 0.19
MACD 0.00 0.12
Stochastic Oscillator 64.06 96.67

Price Performance

Historical Comparison
BRBS
MYGN

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: